Announcing our new Gold Partner: Nanoform
The Nanomed Zone is delighted to welcome Nanoform (Helsinki, Finland) as its inaugural Gold Development Partner.
Nanoform is an innovative nanoparticle medicine enabling company, which works together with pharma and biotech partners globally to reduce attrition in clinical trials and enhance their molecules’ formulation performance through its nanoforming™ services.
The company’s multi-patented and scalable Controlled Expansion of Supercritical Solutions (CESS®) technology produces nano-formed active pharmaceutical ingredient particles that are below 200nm in size, in some cases as small as 10nm. This capability can enable poorly soluble, small-molecule drugs in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. The company has also launched a biologics offering that can create biological nanoparticles as small as 50nm. Nanoform’s unique technologies provides novel opportunities in many value-enhancing, drug delivery applications.
As a Gold Development Partner, Nanoform joins The Nanomed Zone in its launch year as a key partner in the journey to growing the Zone into the ultimate resource for the nanomedicine community. Launched in spring 2020, The Nanomed Zone had an incredibly busy first year, not least in covering the COVID-19 pandemic and the role that nanomedicine plays in vaccine development.
As the Zone continues to strive to serve the dynamic and diverse nanomedicine community, Nanoform will contribute insights and expert opinions. Throughout this partnership, members of The Nanomed Zone can expect insightful articles, videos and webinars from the Zone and Nanoform, who will be working together to benefit the whole nanomedicine community.
Lauren Pulling, Publisher of The Nanomed Zone, commented: “We’re so pleased to welcome Nanoform into The Nanomed Zone family as our first Development Partner. We look forward to sharing the latest news and views from Nanoform, and thank them for their support as we continue to grow the Zone – I’m sure this is the start of a fantastic partnership!”
Christian Jones, Nanoform CCO, stated: “If the pharma industry is to advance, clear communication of the benefits offered by new innovations is essential. We are pleased to have this opportunity to collaborate with The Nanomed Zone to share our insights and latest news, and look forward to a long and successful partnership.”
Find out more about Nanoform below:
- Video: Watch Christian Jones, Chief Commercial Officer at Nanoform, discuss some of the challenges that exist in the current drug discovery and development market, how nanoparticles and nanotechnology may impact drug delivery, pharmaceutical efficiency and drug doses, and what Nanoform’s mission in all this is
- News: First-in-human trial of CESS®-nanoformed drug on track to begin by end of 2020
Nanoform announces biological nanoparticle forming technology - Find out more about Nanoform here >>>
Want to join The Nanomed Zone as a Development Partner? Submit our contact form below to find out more – one of the team will get back to you within 48 hours
hbspt.forms.create({
portalId: “6893718”,
formId: “27fea5a5-74e6-4d89-ba59-57a1c799e876”
});
